ARTICLE | Clinical News
Chemex Pharmaceuticals Inc. regulatory update
April 24, 1995 7:00 AM UTC
CHMX refiled its NDA for Amlexanox, a treatment for aphthous ulcers (canker sores). In November, the FDA refuse to review the submission because the manufacturing facility was under renovation. The bu...